pyrazines has been researched along with transferrin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sanders-Bush, E; Tsutsumi, M | 1 |
BURK, D; FIALA, S | 2 |
Funaki, T; Ichijo, N; Kon, S; Natsume, W; Satake, M; Tanabe, K; Watanabe, T | 1 |
Almeida, GM; Coelho, MA; Frasco, MF; Pereira, Mdo C; Santos-Silva, F | 1 |
5 other study(ies) available for pyrazines and transferrin
Article | Year |
---|---|
5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor.
Topics: Animals; Cells, Cultured; Choroid Plexus; Epithelium; Lysergic Acid Diethylamide; Male; Phosphatidylinositols; Pyrazines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Transferrin | 1990 |
On the mode of iron binding by siderophilin, conalbumin, hydroxylamine, aspergillic acid, and other hydroxamic acids.
Topics: Conalbumin; Gene Expression Regulation; Hydroxamic Acids; Hydroxylamine; Hydroxylamines; Iron; Pyrazines; Transferrin | 1949 |
A SMAP gene family encoding ARF GTPase-activating proteins and its implication in membrane trafficking.
Topics: ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Amino Acid Sequence; Animals; Cadherins; Chlorocebus aethiops; COS Cells; GTPase-Activating Proteins; Humans; Hydrazines; Interleukin-2 Receptor alpha Subunit; Membrane Glycoproteins; Membrane Proteins; Mice; Molecular Sequence Data; Protein Transport; Pyrazines; Quinolines; Sequence Alignment; Small Ubiquitin-Related Modifier Proteins; Transferrin; Two-Hybrid System Techniques | 2008 |
On the nature of iron binding by siderophilin, conlbumin, hydroxylamine, aspergillic acid, and related hydroxamic acids.
Topics: Hydroxamic Acids; Hydroxylamine; Hydroxylamines; Iron; Pyrazines; Transferrin | 1948 |
Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
Topics: Boronic Acids; Bortezomib; Cell Death; Cell Line, Tumor; Endocytosis; Humans; Lactic Acid; Nanoparticles; Pancreatic Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proteasome Inhibitors; Pyrazines; Spectroscopy, Fourier Transform Infrared; Telomerase; Transferrin | 2015 |